期刊文献+

结核分枝杆菌esat6-cfp10融合基因疫苗的构建及表达 被引量:4

Construction and expression of fused gene vaccine esat6-cfp10 of Mycobacterium tuberculosis
下载PDF
导出
摘要 目的:构建结核分枝杆菌esat6 cfp10融合基因疫苗 并对其在体外进行表达.方法:用PCR技术从MTB毒株 H37Rv基因组DNA中扩增cfp10基因,以HindⅢ和EcoRⅠ双 酶切后克隆入含esat6基因的pGEM 7zf(+)载体中,将测序 正确的esat6 cfp10融合基因按照BamHⅠ和EcoRⅠ酶切位点 亚克隆入真核表达载体pcDNA3.1(+),重组质粒酶切鉴定 正确后以脂质体转染CHO细胞,分别以RT PCR方法检测 mRNA表达和间接免疫荧光技术检测目的蛋白的表达. 结果:PCR获得的cfp10基因序列与文献报道一致,大小约为 350bp.重组真核表达质粒酶切后可获得约630bp的融合 esat6 cfp10基因片段.RT PCR可获得大小约为350bp的 cfp10基因,间接免疫荧光检测后表达有Esat6 Cfp10蛋白的阳 性细胞着染.结论:成功克隆结核分枝杆菌cfp10基因,构建 了融合有esat6 cfp10基因的真核表达质粒并对其在体外进行 了表达. AIM: To construct and express fused gene vaccine esat6-cfp10 of Mycobacterium tuberculosis. METHODS: cfp10 gene was amplified by PCR from H37Rv virulent strain of MTB and was then inserted into pGEM-7zf(+) cloning vector containing esat6 gene. After sequenced, the esat6-cfp10 fused gene was cloned into eukaryotic vector pcDNA3.1(+). This recombinant plasmid was transfected into Chinese Hamster Ovary (CHO) cells by cation liposome. The expression of mRNA and the fused protein were detected by RT-PCR and indirect immunofluorescence technique. RESULTS: The length of PCR product was 350 bp, identical with that reported by GenBank. The 630 bp fragment of the fused esat6-cfp10 gene was obtained by restriction enzyme digestion. RT-PCR suggested that the mRNA was expressed in CHO cells and the positive cells were stained positively by indirect immunofluorescence technique. CONCLUSION: cfp10 gene was successfully cloned and the eukaryotic recombinant plasmid fused esat6-cfp10 was constructed successfully and expressed in CHO cells.
出处 《第四军医大学学报》 北大核心 2005年第3期193-195,共3页 Journal of the Fourth Military Medical University
基金 国家"863"课题(2001AA215201) 国家自然科学基金(30400381)
关键词 结核分枝杆菌 ESAT6 CFP10 基因疫苗 真核表达 Mycobacterium tuberculosis esat6 cfp10 gene vaccine eukaryotic expression
  • 相关文献

参考文献11

  • 1徐志凯.单克隆抗体技术[M].西安:陕西科学技术出版社,1992.54-55.
  • 2范雄林,王丽梅,师长宏,李元,柏银兰,薛莹,徐志凯.结核杆菌cfp10真核载体的构建、表达与基因免疫(英文)[J].第四军医大学学报,2003,24(10):867-869. 被引量:2
  • 3师长宏,范雄林,徐志凯,李元,柏银兰,薛莹.融合表达Ag85B-ESAT6的结核分枝杆菌真核表达载体的构建及其免疫原性[J].第四军医大学学报,2004,25(2):121-124. 被引量:6
  • 4Berthet F, Rasmussen P, Rosenkrands I, et al. A Mycobacterium tuberculosis operon encoding ESAT6 and a novel low-moleclar-mass culture filtrate protein(CFP10)[J]. Microbiology, 1998; 144(11):3195-3203.
  • 5Kumar H, Malhotra D, Goswami S, et al. How far have we reached in tuberculosis vaccine development? [J ]. Crit Rev Microbiol, 2003;29(4):297-312.
  • 6Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual[M]. New York: Cold Spring Harbor Laboratory Press, 1999:584-590.
  • 7Morris S, Kelley C, Howard A, et al. The immunogenicity of single and combination DNA vaccines against tuberculosis [J]. Vaccine, 2000; 18(20):2155-2163.
  • 8Brandt L, Oettinger T, Holm A, et al. Key epitopes on the esat6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis[J]. J Immunol, 1996; 157(8): 3527-3533.
  • 9Orme IM. Beyond BCG: The potential for a more effective TB vaccine[J]. Mol Med Today, 1999;5(11):487-492.
  • 10Skjot R, Oettinger T, Rosenkrands I, et al. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the esat6 family as immunodominant T-cell antigens[J]. Infect Immun, 2000;68(1):214-220.

二级参考文献16

  • 1[1]Flynn JL, Chan J. Immunology of tuberculosis [J]. Annu Rev Immunol, 2001; 19:93-129.
  • 2[2]Fan XL, Li Y, Xu ZK. Research of DNA vaccine of Mycobacterium tuberculosis [J]. Xibao yu Fenzi Mianyixue Zazhi (J Cellular Mol Immunol), 2001; 17(s):121-123.
  • 3[3]Behr M., Wilson MA, Gill WP, Salamon H, Schoolnik GK, Rane S, Small PM. Comparative genomics of BCG vaccine by whole genome DNA microarry [J]. Science, 1999; 284: 1520-1523.
  • 4[4]Dillon DC, Alderson MR, Day CH, Bement T, Campos-Neto A, Skeik Y, Vedvick T, Badaro R, Reed SG, Houghton R. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG [J]. J Clin Microbiol, 2000; 38(9): 3285-3290.
  • 5[5]Van Pinxteren LAH, Ravn P, Agger EM, Pollock J, Anderson P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10 [J]. Clin Diagn Lab Immunol, 2000; 7(2):155-160.
  • 6[2]Brandt L, Feino CJ, Weinreich OA, et al. Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis [J]. Infect Immun, 2002;70(2):672-678.
  • 7[3]Buddle BM, Wards BJ, Aldwell FE, et al. Influence of sensitization to environmental mycobacteria on subsequent vaccination against bovine tuberculosis [J]. Vaccine, 2002;20(15):1126-1133.
  • 8[4]Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients [J]. J Clin Microbiol, 2002;40(8):704-706.
  • 9[7]Antas PR, Oliveira EB, Milagres AS, et al. Kinetics of T cell-activation molecules in response to Mycobacterium tuberculosis antigens [J]. Mem Inst Oswaldo Cruz, 2002;97(8):1097-1099.
  • 10[8]Musser JM, Amin A, Ramaswamy S. Negligible genetic diversity of Mycobacterium tuberculosis host immune system protein targets: Evidence of limited selective pressure [J]. Genetics, 2000;155(1):7-16.

共引文献6

同被引文献47

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部